WO2010028336A3 - Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status - Google Patents
Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status Download PDFInfo
- Publication number
- WO2010028336A3 WO2010028336A3 PCT/US2009/056176 US2009056176W WO2010028336A3 WO 2010028336 A3 WO2010028336 A3 WO 2010028336A3 US 2009056176 W US2009056176 W US 2009056176W WO 2010028336 A3 WO2010028336 A3 WO 2010028336A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- palmitoleate
- lipokine
- biomarker
- fatty acid
- metabolic status
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/062,527 US9239334B2 (en) | 2008-09-08 | 2009-09-08 | Fatty acid C16: 1N7-palmitoleate a lipokine and biomarker for metabolic status |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9510908P | 2008-09-08 | 2008-09-08 | |
US61/095,109 | 2008-09-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010028336A2 WO2010028336A2 (en) | 2010-03-11 |
WO2010028336A3 true WO2010028336A3 (en) | 2010-07-01 |
Family
ID=41797911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/056176 WO2010028336A2 (en) | 2008-09-08 | 2009-09-08 | Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status |
Country Status (2)
Country | Link |
---|---|
US (1) | US9239334B2 (en) |
WO (1) | WO2010028336A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8889739B2 (en) | 2010-07-09 | 2014-11-18 | President And Fellows Of Harvard College | Use of trans-palmitoleate in identifying and treating metabolic disease |
EP3510998A1 (en) * | 2011-03-03 | 2019-07-17 | Tersus Pharmaceuticals, LLC | Compositions and methods comprising c16:1n7-palmitoleate |
EP2975400B1 (en) * | 2013-03-15 | 2019-09-04 | Otsuka Pharmaceutical Co., Ltd. | Composition for use in a method for measuring sugar/fatty acid combustion ratio |
MX2016008045A (en) * | 2013-12-20 | 2016-10-12 | Metabolon Inc | Biomakers of de novo lipogenesis and methods using the same. |
WO2018075622A1 (en) * | 2016-10-19 | 2018-04-26 | University Of Miami | Materials and methods for modulating insulin signaling and preserving podocyte function |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090202519A1 (en) * | 2005-07-20 | 2009-08-13 | The Scripps Research Institute | Compositions and methods for treating gram positive bacterial infection in a mammalian subject |
US20090215681A1 (en) * | 2005-02-15 | 2009-08-27 | Joslin Diabetes Center | Methods of Diagnosis and Treatment of Metabolic Disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5198250A (en) | 1990-07-16 | 1993-03-30 | Lipotech Partners Limited Partnership | Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using |
EP0827402A2 (en) | 1995-05-17 | 1998-03-11 | Cedars-Sinai Medical Center | Compositions containing fatty acids for improving digestion and absorption in the small intestine |
US6576636B2 (en) | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
ATE311113T1 (en) | 1999-12-10 | 2005-12-15 | Loders Croklaan Bv | PALMITOLIC ACID AND ITS USE IN FOODS |
US7025984B1 (en) | 2000-06-26 | 2006-04-11 | The Procter & Gamble Company | Compositions and methods for body weight management |
IL142535A0 (en) | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of inflammation |
DK1406641T3 (en) | 2001-06-18 | 2009-05-04 | Neptune Technologies & Bioress | Curly extracts for the prevention and / or treatment of cardiovascular diseases |
ATE443264T1 (en) | 2001-09-24 | 2009-10-15 | Lipomics Technologies Inc | METHOD FOR USING QUANTITATIVE LIPIDE METABOLONE DATA |
-
2009
- 2009-09-08 US US13/062,527 patent/US9239334B2/en active Active
- 2009-09-08 WO PCT/US2009/056176 patent/WO2010028336A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090215681A1 (en) * | 2005-02-15 | 2009-08-27 | Joslin Diabetes Center | Methods of Diagnosis and Treatment of Metabolic Disorders |
US20090202519A1 (en) * | 2005-07-20 | 2009-08-13 | The Scripps Research Institute | Compositions and methods for treating gram positive bacterial infection in a mammalian subject |
Non-Patent Citations (1)
Title |
---|
HANNAH J. WELTERS ET AL.: "Mono-unsaturated fatty acids protect against L-cell apoptosis induced by saturated fatty acids, serum withdrawal or cytokine exporere", FEBS LETTERS 2004, vol. 560, no. 1, 27 February 2004 (2004-02-27), pages 103 - 108 * |
Also Published As
Publication number | Publication date |
---|---|
US9239334B2 (en) | 2016-01-19 |
US20110213032A1 (en) | 2011-09-01 |
WO2010028336A2 (en) | 2010-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY165142A (en) | Metabolic imprinting effects of specifically designed lipid component | |
MY166016A (en) | Infant nutrition for improving fatty acid composition of brain membranes | |
GT200600112A (en) | TIGECICLINE COMPOSITIONS AND PREPARATION METHODS | |
WO2009149418A3 (en) | Compositions for the in vivo delivery of rnai agents | |
EP3206034A3 (en) | Use of fatty acids in methods for detecting cancer | |
WO2010028336A3 (en) | Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status | |
WO2006010153A3 (en) | Lipid-amino acid conjugates and methods of use | |
WO2009099489A3 (en) | Compositions and methods for improving cardiovascular health | |
TR201905768T4 (en) | Polyunsaturated fatty acids in the treatment of diseases associated with cardiovascular, metabolic, and inflammatory disease areas. | |
WO2010136900A3 (en) | Methods of using krill oil to treat risk factors for metabolic disorders and obesity | |
WO2010065876A3 (en) | Methods and compositions related to th-1 dendritic cells | |
MX2013010076A (en) | COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE. | |
MY169098A (en) | Ready to drink beverages and methods of making thereof | |
BR112012016054A2 (en) | Nutritional compositions comprising fruit flakes including docosahexaenoic acid | |
WO2009120700A3 (en) | Inhibition of dcps | |
MX2012011881A (en) | Methods for treating glucose metabolic disorders. | |
MX2011007222A (en) | Nutritional composition for infants. | |
WO2012034130A3 (en) | Methods and compositions for nucleic acid detection | |
MX2014004709A (en) | Composition for use in the promotion of magnesium absorption and/or magnesium retention. | |
MX2014001767A (en) | Methods for ameliorating symptoms or conditions caused by stress. | |
WO2009098355A8 (en) | Novel use of probiotics | |
ATE533482T1 (en) | WEIGHT REDUCTION METHOD | |
MX2011007188A (en) | Methods for increasing endogenous plasmalogen levels. | |
WO2012006612A3 (en) | Use of trans-palmitoleate in identifying and treating metabolic disease | |
MY187748A (en) | Compositions and method for maintaining/improving cognitive function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09812357 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2011526259 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13062527 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09812357 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |